On 2025-05-15, Vivos Therapeutics, Inc. (VVOS) announced earnings per share of $-0.45 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.44.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-0.39 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-15 | 2025-03-31 | $-0.44 | $-0.45 |
| 2025-03-31 | 2024-12-31 | $-0.43 | $-0.28 |
| 2024-11-14 | 2024-09-30 | $-0.70 | $-0.40 |
| 2024-08-14 | 2024-06-30 | -- | $-0.60 |
| 2024-05-14 | 2024-03-31 | -- | $-1.63 |
| 2024-03-28 | 2023-12-31 | -- | $-3.05 |
| 2023-11-14 | 2023-09-30 | -- | $-1.75 |
| 2023-08-16 | 2023-06-30 | $-3.75 | $-3.75 |
| 2023-06-08 | 2023-03-31 | $-4.25 | $-5.00 |
| 2023-03-30 | 2022-12-31 | $-5.50 | $-5.00 |
| 2022-12-20 | 2022-06-30 | -- | $-8.25 |
| 2022-05-16 | 2022-03-31 | $-7.25 | $-6.50 |
| 2022-03-31 | 2021-12-31 | -- | $-8.50 |
| 2021-11-15 | 2021-09-30 | $-4.00 | $-6.50 |
| 2021-08-12 | 2021-06-30 | $-4.00 | $-4.75 |
| 2021-05-17 | 2021-03-31 | $-4.25 | $-4.75 |
| 2021-03-25 | 2020-12-31 | $-5.25 | $-12.00 |